Fennec Pharmaceuticals Inc. Company Profile
NASDAQ: FENCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 10.63 0.00%
Fennec Pharmaceuticals at a glance
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Research Triangle Park, NC. Fennec Pharmaceuticals is led by Mr. Jeffrey S. Hackman and employs about 35 people. At a market capitalization of $362.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001211583, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Fennec Pharmaceuticals do?
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Business description based on the company's public filings.
Company information
- Legal name
- Fennec Pharmaceuticals Inc.
- Ticker
- NASDAQ: FENC
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Jeffrey S. Hackman
- Employees
- 35
- Headquarters
- 68 TW Alexander Drive, Research Triangle Park, NC, United States
- Phone
- 919 636 4530
- Website
- fennecpharma.com
- Market cap
- $362.60M
- SEC CIK
- 0001211583
Companies similar to Fennec Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SCTXScribe Therapeutics Inc. | 19.23 | +9.45% | $364.06M | vs FENC |
| CCCCC4 Therapeutics Inc. | 2.85 | +1.06% | $350.62M | vs FENC |
| KYTXKyverna Therapeutics Inc. | 6.18 | +0.16% | $382.19M | vs FENC |
| AGENAgenus Inc. | 7.54 | -0.40% | $340.52M | vs FENC |
| ARTVArtiva Biotherapeutics Inc. | 6.80 | -2.86% | $332.45M | vs FENC |
| OCGNOcugen Inc. | 0.9774 | -2.26% | $331.45M | vs FENC |
| CABACabaletta Bio Inc. | 1.95 | -1.02% | $330.61M | vs FENC |
| ZURAZura Bio Limited Class A | 4.13 | -0.96% | $395.77M | vs FENC |